Koroner Revaskülarizasyonda Cerrahi Endikasyonlar

Vineberg AM, Miller G. Internal mammary coronary anastomosis in the surgical treatment of coronary artery insufficiency. Can Med Assoc J, 1951;64:204.

Shumacker HB. The evolution of cardiac surgery. Bloomington, IN: Indiana University Press, 1992.

Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein graft: Seven-year follow- up. JAMA, 1973;223:792-4.

Favaloro RG. Critical analysis of coronary artery bypass graft surgery: A 30-year journey. J An Coll Cardiol, 1998;31:1-63.

Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion. Ann Thorac Surg, 1968;5:334-339.

Kolessov VI. Mammary artery-coronary artery anasto- mosis as method treatment for angina pectoris. J Thorac Cardiovasc Surg, 1967;54:535-44. 7 Effler DB, Vasilii I, Kolesov VI. Pioneer in coronary revascularization (letter). J Thorac Cardiovasc Surg, 1988;96:183.

Loop FD, Lytle BW, Cosgrove DM et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. Nengl J Med, 1986;314:1-6.

European Coronary Surgery Study Group. Long term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet, 1982;1173-80.

CASS Principal Investigators, and their associates. Myocardial infarction and mortality in the coronary artery surgery randomized trial. N Engl J Med, 1984; 310:750-8.

Coronary Artery Surgery Study (CASS): A randomized trial of coronary artery bypass surgery: Quality of life in patients randomly assigned to treatment gro- ups. Circulation, 1983;68:951-60.

Gruentzig AR, Sennig A, Siegenlaler WE. Non-opera- tive dilatation of coronary artery stenoses. Percuta- neous transluminal coronary angioplasty. N Engl J, 1979;301:61-8.

First-year results of CABRI. Coronary Angioplasty ver- sus Bypass Revascularization Investigation: CABRI trial participants. Lancet, 1995;346:1179-84.

Rodriguez A, Boullon F, Perez-Balino N et al. Argentine randomized trial of percutaneous transluminal coro- nary angioplasty versus coronary artery bypass surgery in multi-vessel disease (ERACI): In hospital results and 1-year follow-up ERACI Group. J Am Coll Cardiol, 1993;22:1060-7.

Hamm CW, Reimers J, Ischinger T et al. A randomi- sed study of coronary angioplasty compared with bypass surgery in patients with symptomatic multi- vessel coronary disease: German Angioplasty Bypass Surgery Investigati-on (GABI). N ENGL J Med, 1994;331:1037-43.]

Benetti FJ, Naselli G, Wood M, Geffner L. Direct myo- cardial revascularization without extracorporeal cir- culation. Experience in 700 patients. Chest, 1991;100: 312-6.)

Calafiore AM, Giammarco GD, Teodori G, et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996;61:1658-63; discussion 1664-5.

Schofield PM. Indications for percutaneous and sur- gical revascularization: How far does the evidence base guide us? Heart, 2003;89:565-70.]

Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA. A meta-analysis of randomised trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multi-vessel coro- nary artery disease. Am J Cardiol, 1995;76:1025-9.

King SBI, Lembo NJ, Weintrub WS et al. A randomi- sed trial comparingcoronary angioplasty with coro- nary artery bypass surgery: Emory Angioplasty ver- sus Surgery Trial (EAST). N Engl J Med, 1994;331: 1040-50.

King SBI, Barnhart HX, Kosinski AS et al. Angioplasty or surgery for multi-vessel coronary artery disease: Comparison of eligible registry and randomised pati- ents in the EAST trial and influence of treatment selec- tion on outcomes: Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol, 1997;79:1453-9.

Zhao XQ, Brown BG, Stewart DK et al. Effectiveness of revascularization in the Emory Angioplasty versus Surgery Trial: A randomised comparison of coronary angioplasty with bypass surgery. Circulation, 1996;93:1954-62.

Hoffman SN, TenBrook JA, Wolf MP et al. A meta- analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous tran- sluminal coronary angioplasty: One to eight year outcomes. J Am Coll Cardiol, 2003;41:1293-304.)

Meluzin J, Cerny J, Frelich M et al. Prognostic value of the amount of dysfunctional by viable myocardium in revascularized patients with coronary artery disea- se and left ventricular dysfunction. J Am Coll Cardiol,, 1998;32:912-20.

Kleikamp G, Maleszka A, Reiss N, Stuttgen B, Korfer R. Determinants of mid- and long-term results in pati- ents after surgical revascularization for ischemic car- diomyopathy. Ann Thorac Surg, 2003;75:1406-12.

2Weintraub WS, Clements SD Jr, Crisco LV et al. Determinants of mid and long term results in patients after surgical revascularization for ischemic cardiomyopathy. Ann Thorac Surg, 2003;75:1406-12.

Eagle KM, Guyton RA et al. ACC/AHA Guidelines for CABG Surgery. JACC, 1999;4:1262-347.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesJennifer S. Lawton, MD, FAHA, Chair, Jacqueline E. Tamis-Holland, MD, FAHA, FACC, FSCAI, Vice Chair, Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI, Eric R. Bates, MD, FACC, FAHA, Theresa M. Beckie, PhD, FAHA, James M. Bischoff, MEd, John A. Bittl, MD, FACC, … Circulation Volume 145, Number 3)

Taşdemir O, Zorlutuna Y, Babacan K ve ark. Kötü risk grubunda koroner arter bypass cerrahisi. GATA Bülteni, 1987;29:197-204.

Hirose H, Amano A, Takanashi S, Takahashi A. Coronary artery bypass grafting for patients with poor left ventricular function. Asian Cardiovasc Thorac Ann. 2003; 11: 23-7)

Dauerman HL, Yarzebski J, Gore JM, Lessard D, Goldberg RJ. Use of the invasive management stra- tegy for patients with non-Q wave myocardial infarc tion: An observational database report from Worcester Heart Attack Study. Am Heart J, 2002;143:1033-9.

Manoharan G, Adgey AA. Current management of unstable angina: Lessons from the TACTICS-TIMI 18 trial. Am J Cardiovasc Drugs, 2002;2:237-43.)

Phillips SJ, Kongtahworn C, Skinner JR, Zeff RH. Emergency coronary artery reperfusion: A choice the- rapy for evolving myocardial infarction: Results in 339 patients. J Thorac Cardiovasc Surg, 1983;86:679-88. 33

Kaul TK, Fields BL, Riggins SL et al. Coronary artery bypass grafting within 30 days of an acute myocardi- al infarction. Ann Thorac Surg, 1995;59:1169-76.

Lee JH, Murrell HK, Strony J et al. Risk analysis of coronary bypass surgery after acute myocardial infarction. Surgery, 1997;122:675-80. Herlitz J, Brandrup G, Haglid M et al. Death, mode of death, morbidity and rehospitalization after coronary artery bypass grafting in relation to occurrence of and time since a previous myocardial infarction. Thorac Cardiovasc Surg, 1997;45:109-113.

Applebaum R, House R, Rademaker A et al. Coro- nary artery bypass grafting within thirty days of acute myocardial infarction: Early and late results in 406 pa- tients. J Thorac Cardiovasc Surg, 1991;102:745-752.

Lee DC, Oz MC, Weinberg AD, Ting W. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg, 2003;125:115-9.

Braxton JH, Hammond GL, Letsou GV et al. Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction. Circulation, 1995;92(Suppl II):66-8.

Goodman SG, Langer A, Ross AM et al. Non-Q wave versus Q-wave myocardial infarction after thromboly- tic therapy: Angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries I angiographic substudy: GUSTO-I Angiographic Investigators. Circulation, 1998;97:444-450.

Creswell L, Moulton MJ, Cox JL, Rosenbloom M. Revascularization after acute myocardial infarction. Ann Thorac Surg, 1995;60:19-26.

Verani MS, Taillefer R, Iskandrian AE et al. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multi- center IPPA Viability Trial Investigators. 123I-iodop- henylpentadecanoic acid. J Nucl Med, 2000;41:1299- 307.

Kalra DK, Zoghbi WA. Myocardial hibernation in coronary artery disease. Curr Atheroscler Rep, 2002;4:149-55.)

Flameng WJ, Shivalkar B, Spiessens B et al. PET scan predicts recovery of left ventricular function after coronary artery bypass operation. Ann Thorac Surg, 1997;64:1694-701.

Afridi I, Grayburn PA, Panza JA et al. Myocardial via- bility during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol, 1998;32:921-6.)

Pagely PR, Beller GA, Watson DD et al. Improved outcome after coronary artery bypass surgery in patients with ischemic cardiomyopathy and residual myocar- dial viability. Circulation, 1997;96:793-800.)

Kelly P, Ruskin JN, Vlahakes GJ, Buck. Surgical coronary revascularization in survivors of prehospital cardiac arrest: Its effect on inducible ventricular arrhyth- mias and long-term survival. J Am Coll Cardiol, 1990; 15:267-73.

Smith LR, Harrell FEJ, Rankin JS et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation, 1991;84(Suppl III):245-53. von Oppell UO, Milne D, Okreglicki A, Scott Millar RN. Surgery for ventricular tachycardia of left ventricular origin: Risk factors for success and long-term outcome. Eur J Cardiothorac Surg, 2002;22:762-70.

Smith LR, Harrell FEJ, Rankin JS et al. Determinants of early versus late cardiac death in patients undergo- ing coronary artery bypass graft surgery. Circulation, 1991;84(Suppl III):245-53.

von Oppell UO, Milne D, Okreglicki A, Scott Millar RN. Surgery for ventricular tachycardia of left ventricular origin: Risk factors for success and long-term outco- me. Eur J Cardiothorac Surg, 2002;22:762-70.

Topaz O, Salter D, Janin Y, Vetrovec G. Pharmacologic prevention of acute ischemic complications of coro- nary angioplasty transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardi- omyopathy: Emergency bypass surgery for failed coronary interventions. Cathet Cardiovasc Diagn, 1997;40:55-65.

Park SJ, Kim YH, Park DW, et al.. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011; 364: 1727.

Naik H, White AJ, Chakravarty T, et al.. A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. J Am Coll Cardiol Intv. 2009; 2: 739– 47.

Donatelli F, Benussi S, Triggiani M et al. Surgical treatment for lifethre-atening acute myocardial infarcti- on: A prospective protocol. Eur J Cardiothorac Surg,1997;11:228-33.

Every NR, Maynard C, Cochran RP, Martin J, Weaver WD. Characteristics management and outcome of patients with acute myocardial infarction treated with bypass surgery: Myocardial Infarction Triage and Intervention Investigators. Circulation, 1996;94: (Suppl II):81-6.

Norell MS, Gershlick AH, Pillai R et al. Ventricular sep- tal rupture complicating myocardial infarction: Is earlier surgery justified? Eur Heart J, 1987;8:1281-6.

Muehrcke DD, Blank S, Daggett WM. Survival after repair of postinfarction ventricular septal defects in patients over the age of 70. J Card Surg, 1992;7:290- 300.

Iemura J, Oku H, Otaki M et al. Surgical strategy for left ventricular free wall rupture after acute myocardial infarction. Ann Thorac Surg, 2001;71:201-4.

Tahalele P, Prasmono A, Puruhito et al. Surgical repair of an impending rupture of left ventricular (LV) ane- urysm with septal perforation and rupture of papillary muscle after acute myocarial infarction. Ann Thorac Cardiovasc Surg, 2000;6:401-4.

Parry G, Goudevenos J, Adams PC, Reid DS. Septal rupture after myocardial infarction: Is early surgery worthwile? Eur Heart J, 1992;13:373-82.

Piwnica A. Update in surgical treatment of acute post infarction VSDs and Mis. Eur J Cardiothorac Surg, 1995;9:117-9.)

Tavakoli R, Weber A, Brunner, La Rocca H et al. Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction. Eur J Cardiothorac Surg, 2002;21:818-24.)

Lemery R, Smith HC, Giuliani ER, et al.. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol. 1992; 70: 147– 51.

Coskun KO, Coskun ST, Popov AF, et al.. Experiences with surgical treatment of ventricle septal defect as a post infarction complication. J Cardiothorac Surg. 2009; 4: 3.

Oliva PB, Hammill SC, Edwards WD. Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol. 1993; 22: 720– 6.

Hochman JS, Sleeper LA, Webb JG, et al.. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999; 341: 625– 34.

White HD, Assmann SF, Sanborn TA, et al.. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005; 112: 1992– 2001.

White HD, Assmann SF, Sanborn TA, et al.. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005; 112: 1992– 2001.

Donatelli F, Benussi S, Triggiani M, et al.. Surgical treatment for life-threatening acute myocardial infarction: a prospective protocol. Eur J Cardiothorac Surg. 1997; 11: 228– 33.

Mehta RH, Lopes RD, Ballotta A, et al.. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J. 2010; 159: 141– 7. )

Filizcan U, Kurc E, Cetemen S, et al.. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology. 2011; 62: 68– 73.

Klepzig HJ, Kober G, Satter P, Kaltenbach M. Analysis of 100 emergency aortocoronary bypass operations after percutaneous transluminal coronary angio- plasty: Which patients are at risk for large infarctions? Eur Heart J, 1991;12:946-51.

Barakate MS, Bannon PG, Hughes CF et al. Emergency surgery after unsuccessful coronary angioplasty: A review of 15 years experience. Ann Thorac Surg, 2003;75:1400-5.

Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher CR, Jr. Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty: A 10-year experience. Ann Thorac Surg, 1992;215:425-33.

Borkon AM, Failing TL, Piehler JM et al. Risk analysis of operative intervention for failed coronary angioplasty. Ann Thorac Surg, 1992;54:884-90.

Seshadri N, Whitlow PL, Acharya N et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation, 2002;106:2346-50.

Roy P, de Labriolle A, Hanna N, et al.. Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era. Am J Cardiol. 2009; 103: 950– 3.

Frutkin AD, Mehta SK, Patel T, et al.. Outcomes of 1090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery. Am J Cardiol. 2008; 101: 53– 7.

Ting HH, Raveendran G, Lennon RJ, et al.. A total of 1007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes. J Am Coll Cardiol. 2006; 47: 1713– 21. )

Andreasen JJ, Mortensen PE, Andersen LI, et al.. Emergency coronary artery bypass surgery after failed percutaneous transluminal coronary angioplasty. Scand Cardiovasc J. 2000; 34: 242– 6.

Carey JA, Davies SW, Balcon R, et al.. Emergency surgical revascularisation for coronary angioplasty complications. Br Heart J. 1994; 72: 428– 35. Crossref. )

Stamou SC, Hill PC, Haile E, et al.. Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2006; 131: 28– 33.

Karthik S, Musleh G, Grayson AD, et al.. Effect of avoiding cardiopulmonary bypass in non-elective coronary artery bypass surgery: a propensity score analysis. Eur J Cardiothorac Surg. 2003; 24: 66– 71. )

Azariades M, Fessler CL, Floten HS, Starr A. Five year results of coronary bypass grafting for patients older than 70 years: Role of internal mammary artery. Ann Thorac Surg, 1990;50:940-5.

Brandrup-Wognsen G, Berggren H, Hartford M, Hjalmarson A, Karlsson T, Herlitz J. Female sex associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J, 1996;17:1426-31.

Alexander KP, Anstrom KJ, Muhlbaier LH, et al.. Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol. 2000; 35: 731– 8. )

Ghanta RK, Shekar PS, McGurk S, et al.. Nonelective cardiac surgery in the elderly: is it justified? J Thorac Cardiovasc Surg. 2010; 140: 103– 9 e1.

Engoren M, Arslanian-Engoren C, Steckel D, et al.. Cost, outcome, and functional status in octogenarians and septuagenarians after cardiac surgery. Chest. 2002; 122: 1309– 15.

Circulation. 1998 Sep 29;98(13):1279-85.Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI)

AK Jacobs , SF Kelsey, MM Brooks, DP Faxon, BR Chaitman, V Bittner, MB Mock, BH Weiner, L Dean, C Winston, L Drew, G Sopko. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation. 1998 Sep 29;98(13):1279-85.

A K Jacobs , S F Kelsey, M M Brooks, D P Faxon, B R Chaitman, V Bittner, M B Mock, B H Weiner, L Dean, C Winston, L Drew, G Sopko

O’Connor GT, Morton JR, Diehl MJ et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation, 1993;88:2104-10.

Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early, and late outcome after coronary artery bypass grafting. Ann Thorac Surg, 1999;67:1045-52

Barzilay JI, Kronmal RA, Bittner V et al. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged 65 years (report from the Coronary Artery Surgery Study Registry) Am J Cardiol, 1994;74:334-339.

Calafiore AM, Di Mauro M, Di Giammarco G et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg, 2003;125:144-54.

Cohen A, Katz M, Hauptman E, Schachner A. Chronic obstructive pulmonary disease in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg, 1995;109:574-81. )

Shahian DM, O'Brien SM, Filardo G, et al.. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1–coronary artery bypass grafting surgery. Ann Thorac Surg. 2009; 88 1 Suppl: S2– 22. )

The BARI Investigators. influence of diabetes on 5–year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997; 96: 1761– 9.

Shapira N, Zabatino SM, Ahmed S et al. Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg, 1990;50:268-73.

Clough RA, Leavitt BJ, Morton JR et al. The effect of comorbid illness on mortality outcomes in cardiac surgery. Arch Surg, 2002;137:428-32.

Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populati- ons. Am J Kidney Dis 19:505-513.)

Güler, M., Kirali, K., Toker, M.E., Bozbuga, N., Omeroglu, Different CABG methods in patients with chronic obstructive pulmonary disease. The Annals of Thoracic Surgery, 2001, 71, 152-157.)

Robert Gaynes MD, Barbara Bizek MPH, Jole Mowry, Hanley BSN, RN, Marvin Kirsh MD. Risk factors for nosocomial pneumonia after coronary artery bypass graft operations. The Annals of Thoracic Surgery Volume 51, Issue 2, February 1991, Pages 215-218

Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populati- ons. Am J Kidney Dis 19:505-513.

Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis, 1992;20:32-8.)

Excerpts from United States Renal Data Sytem: Annual data report. Am J Kidney Dis, 1997;30:1-213.)

Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. The pharma- cokinetics of racemic verapamil in patients with impai- red renal function: Coronary artery bypass operation in dialysis patients. Mayo Clin Proc, 1991;66:45-53.

Reusser LM, Osborn LA, White HJ, Sexson R, Crawford MH. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol, 1994;73:965-967.

Rostand SG, Rutsky EA. Coronary artery disease in end-stage renal disease. In: Henrich W, ed. Principals and Practices of Dialysis. Baltimore, MD: Williams & Wilkins, 1993;181-195.

Durmaz I, Yagdi T, Calkavur T et al. Prophylactic dialy- sis in patients with renal dysfunction, undergoing on- pump coronary artery bypass surgery. Ann Thorac Surg, 2003;75:859-64.

Kahn JK, Rutherford BD, McConahay DR et al. Short- and long- term outcome of percutaneous translumi- nal coronary angioplasty in chronic dialysis patients. Am Heart J, 1990;119:484-9.

Rinehart AL, Herzog CA, Collins AJ et al. Greater risk of cardiac events after coronary angioplasty (PTCA) than bypass grafting (CABG) in chronic dialysis pati- ents (abstr). J Am Soc Nephrol, 1992;3:389.

Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation, 2002;106:2207-11.

Survival after coronary revascularization among patients with kidney disease Brenda R Hemmelgarn 1, Danielle Southern, Bruce F Culleton, L Brent Mitchell, Merril L Knudtson, William A Ghali) Circulation, . 2004 Oct 5;110(14):1890-5.

Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol, 1991;18:203-14.

DeBakey ME, Crawford ES, Cooley DA et al. Cerebral arterial insufficiency: one to 11 year results following arterial reconstructive operation. Ann Surg, 1965;161: 921-45.

Brown OW, Hollier LH, Pairolero PC, Kazmier FJ, McCready RA. Abdominal aortic aneurysm and coronary artery disease. Arch Surg, 1981;116:1484-8.

Crawford ES, Bomberger RA, Glaeser DH, Saleh SA, Russell WL. Aortoiliac occlusive disease: Factors.

Jamieson WR, Janusz MT, Miyagishima RT, Gerein AN. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation, 1982;66(Suppl I):92-7.

Birkmeyer JD, Quinton HB, O’Connor NJ et al. The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery: Northern New England Cardiovascular Disease Study Group. Arch Surg, 1996;131:316-21.

Birkmeyer JD, O’Connor GT, Quinton HB et al. The effect of peripheral vascular disease on in hospital mortality rates with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. J Vasc Surg, 1995;21:445-52.

Loponen P, Taskinen P, Laakkonen E et al. Peripheral vascular disease as predictor of outcome after coronary artery bypass grafting. Scand J Surg, 2002;2:160-5.

L. Grover MD, Karl, Hammermeister MD, Cecil Burchfiel PhD. Initial report of the veterans administration preoperative risk assessment study for cardiac surgery, Frederick Cardiac Surgeons of the Department of Veterans Affairs. The Annals of Thoracic Surgery Volume 50, Issue 1, July 1990, Pages 12-26

T L Higgins , F G Estafanous, F D Loop, G J Beck, J M Blum, L Paranandi. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 1992 May 6;267(17):2344-8.

G T O'Connor , S K Plume, E M Olmstead, L H Coffin, J R Morton, C T Maloney, E R Nowicki, D G Levy, J F Tryzelaar, F Hernandez, et al. Multivariate prediction of in hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992 Jun;85(6):2110-8.

J D Birkmeyer , G T O'Connor, H B Quinton, M A Ricci, J R Morton, B J Leavitt, D C Charlesworth, F Hernandez, M D McDaniel. The effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. J Vasc Surg. 1995 Mar;21(3):445-52.

Yau JM, Alexander JH, Hafley G, et al.. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). Am J Cardiol. 2008; 102: 546– 51.

Saara Weman MD b, Pekka Karhunen MD c d, Antti Penttilä MD a, Antero A Järvinen MD, PhD b, Ulla-Stina Salminen MD b. Reperfusion injury associated with one-fourth of deaths after coronaryartery bypass grafting Author links open overlay panel. The Annals of Thoracic Surgery Volume 70, Issue 3, September 2000, Pages 807-812

Ferreira MD , Mario Burgos MD , Jose Milei MD , Susana Llesuy PhD , Luis Molteni MD , Hector Hourquebie MD , Alberto Boveris PhD. Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium. The Journal of Thoracic and Cardiovascular Surgery Volume 100, Issue 5, November 1990, Pages 708-714

G Ambrosio, L C Becker, G M Hutchins, H F Weisman, and M L WeisfeldtReduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation Volume 74, Number 6

AML Seymour, JC Chatham, GK Radda. Effects of repeated low calcium perfusion on the rat heart: A grandual induction of calcium related damage Journal of molecular and cellular cardiology, J Mol Cell Cardiol. 1990; 22:131-14

Chowdhury UK, Malik V, Yadav R, et al.. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release. J Thorac Cardiovasc Surg. 2008; 135: 1110– 9.

Ghorbel MT, Cherif M, Mokhtari A, et al.. Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery. Physiol Genomics. 2010; 42: 67– 75.

Castellheim A, Hoel TN, Videm V, et al.. Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg. 2008; 85: 1994– 2002.

Serrano CV, Souza JA, Lopes NH, et al.. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study. J Crit Care. 2010; 25: 305– 12.

Joseph F Sabik 3rd 1, Eugene H Blackstone, Penny L Houghtaling, Peter A Walts, Bruce W Lytle, Is reoperation still a risk factor in coronary artery bypass surgery? Ann Thorac Surg. 2005 Nov;80(5):1719-27.

Terrence M. Yau, MD, MSc ∙ Michael A. Borger, MD ∙ Richard D. Weisel, MD ∙ Joan Ivanov, MSc. The changing pattern of reoperative coronary surgery. Trends in 1230 consecutive reoperations. Surgery for Acquired Cardiovascular Disease. Volume 120, Issue 1, P156-163 July 2000.

Pick AW, Mullany CJ, Orszulak TA, Daly RC, Schaff HV. Third and fourth operations for myocardial ischemia: Short-term results and long-term survival. Circulation, 1997;96(Suppl I):26-31.

Brenowitz JB, Johnson WD, Kayser KL et al. Coronary artery bypass grafting for the third time or more: Results of 150 consecutive cases. Circulation, 1988;78(Suppl I):166-70.

Christenson JT, Simonet F, Schmuziger M. The impact of a short interval (1 year) between primary and reoperative coronary artery bypass grafting pro- cedures. Cardiovasc Surg, 1996;4:801-7.

Pick AW, Mullany CJ, Orszulak TA, Daly RC, Schaff HV. Third and fourth operations for myocardial ische- mia: Short-term results and long-term survival. Circulation, 1997;96(Suppl I):26-31.

Brenowitz JB, Johnson WD, Kayser KL et al. Coronary artery bypass grafting for the third time or more: Results of 150 consecutive cases. Circulation, 1988;78(Suppl I):166-70.

Christenson JT, Simonet F, Schmuziger M. The impact of a short interval (1 year) between primary and reoperative coronary artery bypass grafting pro- cedures. Cardiovasc Surg, 1996;4:801-7.

Lytle BW, Navia JL, Taylor PC et al. Third coronary artery bypass operations: Risks and costs. Ann Thorac Surg, 1997;64:1287-95.)

) D’Ancona G, Karamanoukian H, Ricci M et al. Reoperative coronary artery bypass grafting with and without cardiopulmonary bypass: determinants of perioperative morbidity and mortality. Heart Surg Forum, 2001;4:152-8.

Kaul TK, Fields BL, Wyatt DA, Jones CR, Kahn DR. Reoperative coronary artery bypass surgery: Early. 68 and late results and management in 1300 patients. J Cardiovasc Surg (Torino), 1995;36:303-12. 68 Cameron A, Kemp HGJ, Green GE. Reoperation for coronary artery disease: 10 years of clinical follow-up. Circulation, 1988;78(Suppl I):158-162

van Eck FM, Noyez L, Verheugt FW, Brouwer RM. Analysis of mortality within the first six months after coronary reoperation. Ann Thorac Surg, 2002;74: 2106-12.

Zorlutuna Y, Karagöz YH, Babacan K et al. Koroner arter hastalığında reoperasyonlar. Türkiye Klinikleri Kardiyoloji, 1989;2:143-5.

Carpentier A, Guermonprez JL, Deloche A, Frechette C, DuBost C. The aorta-to-coronary radial artery bypass graft: A technique avoiding pathological changes in grafts. Ann Thorac Surg, 1973;16:111-21.

Gunaydin S, Modine T, Sari T, Zorlutuna Y, Gourlay T. Clinical efficacy of two phase leukocyte filtration in high risk patients undergoing coronary revascularization with cardiopulmonary bypass. J Extra Corpor Technol. 2009 Sep;41(3):149-56.

Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):135-42.

Gunaydın S, Sarı T, McCusker K, Vijay V, Aydın H, Farsak B, Yorgancıoğlu C, Sargon M, Kirazlı Ş, Kocakulak M, Akçelik O, Özışık K, Tezcaner T, Zorlutuna Y. Clinical evaluation of strategic leukofiltration with surface modification: Enhanced preservation or fantasy. Firatition 1 (1) 2005 57.

Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):135-42.

GLR61 Shroyer AL, Grover FL, Hattler B, et al.. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009; 361: 1827– 37.)

Minimally invasive and robotic coronary artery bypass grafting – a 25 - year reviev, Johannes Bonatti atal., J Thorac Dis November 2020.

Nadejda Monsefi, Eissa Alaj , Sami Sirat and Farhad Bakhtiary, Department of Cardiac Surgery, University Hospital Bonn, Bonn, Germany, 2Department of Cardiac Surgery, Heart Center Siegburg, Siegburg, Germany, Postoperative results of minimally invasive direct coronary artery bypass procedure in 234 patients . Frontiers in Cardiovascular Medicine, 10 January 2023

Joseph T McGinn Jr , Saif Usman, Harry Lapierre, Vijayasimha R Pothula, Thierry G Mesana, Marc Ruel, Minimally invasive coronary artery bypass grafting: dual-center experience in 450 consecutive patients.Circulation. 2009 Sep 15;120(11 Suppl):S78-84.

Motallebzadeh R, Bland JM, Markus HS, et al.. Neurocognitive function and cerebral emboli: randomized study of on-pump versus off-pump coronary artery bypass surgery. Ann Thorac Surg. 2007; 83: 475– 82.

Nesher N, Frolkis I, Vardi M, et al.. Higher levels of serum cytokines and myocardial tissue markers during on-pump versus off-pump coronary artery bypass surgery. J Card Surg. 2006; 21: 395– 402.

Shroyer AL, Grover FL, Hattler B, et al.. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009; 361: 1827– 37. Crossref. PubMed.

Khan NE, De Souza A, Mister R, et al.. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 2004; 350: 21– 8.

Nathoe HM, van Dijk D, The Octopus Study Group, et al. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med. 2003; 348: 394– 402.

Hannan EL, Wu C, Smith CR, et al.. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007; 116: 1145– 52.

Kuss O, von SB, Borgermann J. Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg. 2010; 140: 829– 35.

Bainbridge D, Martin JE, Cheng DC. Patient-controlled versus nurse-controlled analgesia after cardiac surgery—a meta-analysis. Can J Anaesth. 2006; 53: 492– 9.

Lowenstein E, Hallowell P, Levine FH, et al.. Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med. 1969; 281: 1389– 93.

Reiz S, Balfors E, Sorensen MB, et al.. isoflurane—a powerful coronary vasodilator in patients with coronary artery disease. Anesthesiology. 1983; 59: 91– 7.

van Dijk, D, Diephuis, JC, Nierich, AP, Keizer, AM, Kalkman, CJ. Beating heart versus conventional cardiopulmonary bypass: the Octopus experience: a randomized comparison of 281 patients undergoing coronary artery bypass surgery with or without cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth 2006;10:167-170.

Widimsky, P, Straka, Z, Stros, P, et al. One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation 2004;110:3418-3423.

Fisk RL, Brook CH, Callagahan JC, Dvorkin J. Experience with the radial artery graft for coronary artery bypass. Ann Thorac Surg, 1976;21:513-8.

Lytle BW, Loop FD, Cosgrove DM et al. Long- term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg, 1985;89:248-58.

Suma H, He GW. Arterialization in coronary artery surgery in Japan and Hong Kong. Semin Thorac Cardiovasc Surg, 2002;14:346-53.

Tezcaner T, Catav Z, Yorgancıoğlu C et al. Coronary artery bypass surgery without cardiopulmonary bypass. Cardiovasc Surg, 1998;6:139-44.

Johannes Bonatti, Stephanie Wallner, Ingo Crailsheim, Martin Grabenwöger, Bernhard Winkler , Minimally invasive and robotic coronary artery bypass grafting a 25 year review. J Thorac Dis. 2021 Mar; 13(3): 1922–1944.

Schachner T, Bonaros N, Wiedemann D, Lehr EJ, Weidinger F, Feuchtner G, et al. Predictors, causes, and consequences of conversions in robotically enhanced totally endoscopic coronary artery bypass graft surgery. Ann Thorac Surg. 2011;91(3):647–653.

Robotic Cardiac Surgery: The Future Gold Standard or An Unnecessary Extravagance? Amer Harky, MBChB, MSc, MRCS1 and Syed Mohammad Asim Hussain, MBChB, MSc, MRCS Braz J Cardiovasc Surg. 2019 Jul-Aug; 34(4): XII–XIII.

Theo Kofidis , Maximilian Y Emmert, Hans Gerd Paeschke, Lorenz S Emmert, Ruoyu Zhang, Axel Haverich,Long-term follow-up after minimal invasive direct coronary artery bypass grafting procedure: a multifactorial retrospective analysis at 1000 patient-years.Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):990-4.

Alman Alberto Fortunato, Piroze M. Davierwala, 2022, Toronto, KanadaJOVS(JournalOfVisualizeSurgery)(Editoryal yorum).

Balacumaraswami L, Taggart DP. Intraoperative imaging techniques to assess coronary artery bypass graft patency. Ann Thorac Surg. 2007;83:2251–7.

Serruys PW, Morice MC, Kappetein AP, et al.. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961– 72.

Kappetein AP, Mohr FW, Feldman TE, et al.. Comparison of coronary bypass surgery with drug eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011; 17: 2125– 34.

Jennifer S. Lawton, MD, FAHA, Chair, Jacqueline E. Tamis-Holland, MD, FAHA, FACC, FSCAI, Vice Chair, Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI, Eric R. Bates, MD, FACC, FAHA, Theresa M. Beckie, PhD, FAHA, James M. Bischoff, MEd, John A. Bittl, MD, FACC, Brittany A. Zwischenberger, MD. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation Volume 145, Number 3.